Skip to main content

Advertisement

Table 3 Diagnosis definitions used in the study, presented with the number of patients

From: What is the impact of regulatory guidance and expiry of drug patents on dementia drug prescriptions in England? A trend analysis in the Clinical Practice Research Datalink

Diagnosis Definition Patients
Probable AD Patients with one or more codes on the list ‘probable AD’. Patients may also have codes on the lists ‘possible AD’, ‘donepezil’, ‘rivastigmine’, ‘galantamine’ and ‘memantine’. 10,651
Possible AD Patients with one or more codes on the list ‘possible AD’. Patients may also have codes on the lists ‘donepezil’, ‘rivastigmine’, ‘galantamine’ and ‘memantine’. 12,167
Non-AD and mixed dementias Patients with one or more codes on any of the following lists: ‘probable AD’, ‘possible AD’, ‘other dementia’, ‘vascular dementia’, ‘non-specific dementia’, ‘donepezil’, ‘rivastigmine’, ‘galantamine’ and ‘memantine’, who do not meet the above criteria. 17,384
  1. AD Alzheimer’s disease
  2. The data presented are restricted to patients who received a diagnosis prior to 1st January 2016 and are from an English practice with a last data collection date in 2016 to reflect the main analysis. The total number of patients with ‘any dementia’ is 40,202